Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Liesbeth Delbaere

Faculty of Medicine and Health Sciences > Department of Head and Skin

ORCID iD: 0000-0002-4589-4381

Add to list
- Journal Article
- A1
- open access
Hot spots for clinical signs of disease activity in vitiligo

Liesbeth Delbaere (UGent) , Jérôme Van Causenbroeck, Jolien Duponselle (UGent) , Céline Van Goethem, Reinhart Speeckaert (UGent) and Nanja van Geel (UGent)

(2024) EXPERIMENTAL DERMATOLOGY. 33(1).
Add to list
- Conference Paper
- C3
The measurement quality of PROMS used in dermatology

Zoë De Schryver (UGent) , Liesbeth Delbaere (UGent) , Caroline B Terwee and Sandrine Herbelet (UGent)

(2024) QUALITY OF LIFE RESEARCH. In Quality of Life Research 33(Supplement 1). p.S230-S230
Add to list
Predictive value of disease activity signs in vitiligo : an observational study

Liesbeth Delbaere (UGent) , Jolien Duponselle (UGent) , Sandrine Herbelet (UGent) , Reinhart Speeckaert (UGent) and Nanja van Geel (UGent)

(2024) EXPERIMENTAL DERMATOLOGY. 33(9).
Add to list
- Journal Article
- A1
- open access
Exploring the severity strata of disease activity and repigmentation in vitiligo based on validated Physician Global Assessment (PGA) scores

Nanja van Geel (UGent) , Liesbeth Delbaere (UGent) , Laura Mertens, Virginie Vandaele, Lien Depaepe, Jérôme Van Causenbroeck, Sofie De Schepper (UGent) , Laura Van Coile (UGent) , Astrid Van Reempts, Ann-Sophie De Vos, et al.

(2024) JOURNAL OF CLINICAL MEDICINE. 13(9).
Add to list
- Conference Paper
- C3
- open access
SA-VES : a valid, reliable and feasible tool to assess patient perspective on vitiligo extent

Zoë De Schryver (UGent) , Liesbeth Delbaere (UGent) , Jolien Duponselle (UGent) , Sandrine Herbelet (UGent) , Reinhart Speeckaert (UGent) and Nanja van Geel (UGent)

(2024) Belgian Dermatology Days 2024, Abstracts.
Add to list
- Conference Paper
- C3
Creating awareness for the content validity of PROMs

Sandrine Herbelet (UGent) , Liesbeth Delbaere (UGent) , Lidwine B. Mokkink and Caroline B. Terwee

(2024) Research Day 2024, Abstracts.
Add to list
Clinician‐reported outcome measures for the assessment of vitiligo : a scoping review

Nanja van Geel (UGent) , Jolien Duponselle (UGent) , Liesbeth Delbaere (UGent) , Sandrine Herbelet (UGent) , Viktoria Eleftheriadou, Khaled Ezzedine, Maxine Forman, Amit Garg, Iltefat H. Hamzavi, Julien Seneschal, et al.

(2023) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 37(11). p.2231-2242
Add to list
- Conference Paper
- C3
- open access
Prognostic value of the vitiligo disease activity signs

Liesbeth Delbaere (UGent) , Jolien Duponselle (UGent) , Sandrine Herbelet (UGent) , Reinhart Speeckaert (UGent) and Nanja van Geel (UGent)

(2023) Belgian Dermatology Days 2023, Abstracts.
Add to list
- Journal Article
- A2
- open access
Biomarkers and clinical indicators of disease activity in vitiligo

Liesbeth Delbaere (UGent) , Reinhart Speeckaert (UGent) , Sandrine Herbelet (UGent) , Arno Belpaire (UGent) , Jolien Duponselle (UGent) and Nanja van Geel (UGent)

(2022) DERMATOLOGICAL REVIEWS. 3(5). p.289-307
Add to list
- Conference Paper
- C3
Hot spots of clinical signs of disease activity in Vitiligo

Liesbeth Delbaere (UGent) , Jérôme Van Causenbroeck, Céline Van Goethem, Jolien Duponselle (UGent) , Sandrine Herbelet (UGent) , Reinhart Speeckaert (UGent) and Nanja van Geel (UGent)

(2022) 7th Congress of the Skin Inflammation & Psoriasis International Network Congress (SPIN 2022), Abstracts.

1
2

Next →